Success Metrics

Clinical Success Rate
97.1%

Based on 101 completed trials

Completion Rate
97%(101/104)
Active Trials
25(15%)
Results Posted
18%(18 trials)
Terminated
3(2%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_3
5
3%
Ph phase_2
10
6%
Ph not_applicable
132
77%
Ph phase_4
14
8%
Ph phase_1
1
1%

Phase Distribution

2

Early Stage

10

Mid Stage

19

Late Stage

Phase Distribution163 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
1(0.6%)
Phase 2Efficacy & side effects
10(6.1%)
Phase 3Large-scale testing
5(3.1%)
Phase 4Post-market surveillance
14(8.6%)
N/ANon-phased studies
132(81.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.3%

101 of 106 finished

Non-Completion Rate

4.7%

5 ended early

Currently Active

25

trials recruiting

Total Trials

172

all time

Status Distribution
Active(36)
Completed(101)
Terminated(5)
Other(30)

Detailed Status

Completed101
unknown30
Recruiting18
Not yet recruiting8
Active, not recruiting7
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
172
Active
25
Success Rate
97.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 11 (0.6%)
Phase 210 (6.1%)
Phase 35 (3.1%)
Phase 414 (8.6%)
N/A132 (81.0%)

Trials by Status

not_yet_recruiting85%
terminated32%
enrolling_by_invitation32%
completed10159%
recruiting1810%
active_not_recruiting74%
unknown3017%
withdrawn21%

Recent Activity

Clinical Trials (172)

Showing 20 of 172 trialsScroll for more
NCT07449962Not Applicable

Effect of Counselling Using Lifestyle Medicine Assessment Tool on Hypertensive Patients

Not Yet Recruiting
NCT05228522Not Applicable

Preventing Diabetes in Latino Families

Active Not Recruiting
NCT02842957Not Applicable

An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)

Completed
NCT03440736Phase 4

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Completed
NCT06903923Phase 2

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Recruiting
NCT05744479Phase 4

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

Recruiting
NCT06395558Not Applicable

intErnet-based iNterventions FOR Cardiac arrEst suRvivors

Recruiting
NCT05174871Not Applicable

Time-Restricted Feeding in Children and Adolescents With Obesity

Active Not Recruiting
NCT05653258Phase 2

Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects

Recruiting
NCT03441321Not Applicable

Social-Media Intervention in Reducing Tanning in High-Risk Tanners

Completed
NCT01868230Not Applicable

Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women

Completed
NCT03860558Not Applicable

Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

Active Not Recruiting
NCT07128238Not Applicable

Research on "Metabolic Adaptation" in Obese People

Not Yet Recruiting
NCT07340177Phase 4

Xiaojin Pill/Neixiao Luoli Pill for the Treatment of Thyroid Nodules

Not Yet Recruiting
NCT07341841Not Applicable

Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study

Enrolling By Invitation
NCT06948825Phase 2

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

Recruiting
NCT07310407Phase 2

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Not Yet Recruiting
NCT06755645

Transforming Parkinson's Care With Predictive Algorithms

Not Yet Recruiting
NCT05739162Not Applicable

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

Recruiting
NCT03146156Not Applicable

Lifestyle Intervention in Preparation for Pregnancy (LIPP)

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
172